Skip to content

Thomas J. Connor

3 papers in the library · 143 citations · publishing 2003-2010

Papers

Sort Most recent Most cited

Methylenedioxymethamphetamine (‘Ecstasy’)‐induced immunosuppression: a cause for concern?

British Journal of Pharmacology May 27, 2010 Noreen T. Boyle, Thomas J. Connor 42 citations

Methylenedioxymethamphetamine (MDMA; 'Ecstasy') is a ring-substituted amphetamine and a popular drug of abuse. In addition to ability to induce euphoria, MDMA abuse is associated with a range of acute and long-term hazardous effects. This paper is focused on once such adverse effect: its ability to negatively impact on functioning of the immune system. Research demonstrates that MDMA has...

Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): a stressor on the immune system

Immunology March 30, 2004 Thomas J. Connor 101 citations

Summary Drug abuse is a global problem of considerable concern to health. One such health concern stems from the fact that many drugs of abuse have immunosuppressive actions and consequently have the potential to increase susceptibility to infectious disease. This article is focused on the impact of the amphetamine derivative, methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) on immunity....

Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine.

The European journal of neuroscience August 2003 Andrew Harkin, Eamonn Shanahan, John P Kelly et al.

The effect of prior exposure to methylenedioxyamphetamine (MDA) on behavioural and neurochemical responses to fluoxetine were assessed in a rat model of antidepressant action. MDA (7.5 mg/kg, i.p.) was administered to rats twice daily for 4 consecutive days, and 4 weeks later the behavioural effect of fluoxetine (5 or 20 mg/kg; i.p. x 3) was examined in the modified rat forced-swimming test. In...